Stock screenerAll disclosures →
EDGAR →
CCCC
Conviction 92HealthcareScan · Thu, Jun 25, 2026CCCC$4.40+3.41%
ResistanceSupportVol 14Vol MA14 2.46M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price4.40
Change+3.41%
Gap+0.47%
Rel volume1.60×
Avg volume2.64M
Avg $ vol10.82M
SMA 204.01
SMA 503.48
SMA 2002.69
Price vs 50+26.38%
Price vs 200+63.37%
MA stackbullish
50/200 cross—
Supertrendup · 3.41
RSI (14)66
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D92 / 82
ADX (14)25
+DI / −DI25 / 15
RSI divergence—
MACD divergence—
ATR %+7.67%
ADR %9.27%
52w high4.40
52w low1.40
From 52w high+0.00%
Above 52w low+213.93%
New 52w highYes
SqueezeOff
Bollinger width25.60%
%B0.87
Donchian pos82.46%
Donchian high4.60
Donchian low3.44
AVWAP (52w high)4.10
vs AVWAP high+7.32%
AVWAP (52w low)2.76
vs AVWAP low+59.27%
OBV trendUp
Chaikin MF (20)-0.08
Today vs 20d1.60×
Avg vol (14d)2.46M
Avg vol (20d)2.64M
Avg $ vol (20d)10.82M
Market cap485.94M
RS 3m (vs SPY)+57.74%
RS 6m (vs SPY)+101.62%
RS line new highYes
Trend template8/8
Technical rank94.8
1 week+12.12%
1 month+25.93%
3 months+63.38%
6 months+110.29%
1 year+181.73%
YTD+127.72%
P/E-4.63
P/B2.07
P/S13.52
P/FCF-4.89
EPS-1.27
Div yield—
ROE-44.82%
ROA-31.93%
Debt/Eq0.00
Current9.00
EV/EBITDA—
Gross margin—
Net margin-292.08%
Rev growth1.02%
EPS growth0.31%
Price target10.33
Target upside135.04%
Analyst ratingBuy
Institutional81.91%
Ent. value424.67M
Revenue6.15M
Net income-25.13M
Gross profit—
Free cash flow-99.3M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out110.57M
Employees104
ListedFri, Oct 2, 2020
Free float75.13M
Float %77.5%
Short interest21.65M
Days to cover9.4d
Short volume47.1%
Squeeze score79 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.23 · 2 est
Last EPS vs est−$0.20 vs −$0.21
Last surprise+4.8% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank94.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.54
Support2.92
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CCCC
No recent disclosed trades by Congress in CCCC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CCCC · 1 buy · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Anderson Kenneth Carl Director · Stock Option (Right to Buy) · 2026-06-01 | Exercise | 1.07K | $0 | 2026-06-01 | 2026-06-04 |
Anderson Kenneth Carl Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-04 |
Anderson Kenneth Carl Director · Common Stock · 2026-06-01 | Exercise | 1.07K | $2K | 2026-06-01 | 2026-06-04 |
SEC filings
EDGAR filings in CCCC · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.